Vistagen Therapeutics Inc (VTGN)
2.53
-0.08
(-3.07%)
USD |
NASDAQ |
Nov 21, 16:00
2.54
+0.01
(+0.40%)
After-Hours: 20:00
Vistagen Therapeutics Total Assets (Quarterly): 102.50M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 102.50M |
June 30, 2024 | 113.55M |
March 31, 2024 | 123.65M |
December 31, 2023 | 131.07M |
September 30, 2023 | 42.20M |
June 30, 2023 | 15.03M |
March 31, 2023 | 21.09M |
December 31, 2022 | 29.71M |
September 30, 2022 | 40.70M |
June 30, 2022 | 58.73M |
March 31, 2022 | 74.64M |
December 31, 2021 | 90.54M |
September 30, 2021 | 100.50M |
June 30, 2021 | 103.91M |
March 31, 2021 | 108.28M |
December 31, 2020 | 109.27M |
September 30, 2020 | 20.27M |
June 30, 2020 | 6.167M |
March 31, 2020 | 5.772M |
December 31, 2019 | 5.331M |
September 30, 2019 | 8.736M |
June 30, 2019 | 12.95M |
March 31, 2019 | 14.01M |
December 31, 2018 | 7.522M |
September 30, 2018 | 8.889M |
Date | Value |
---|---|
June 30, 2018 | 8.255M |
March 31, 2018 | 11.28M |
December 31, 2017 | 14.24M |
September 30, 2017 | 2.618M |
June 30, 2017 | 2.437M |
March 31, 2017 | 3.712M |
December 31, 2016 | 5.876M |
September 30, 2016 | 7.023M |
June 30, 2016 | 8.758M |
March 31, 2016 | 0.9898M |
December 31, 2015 | 2.012M |
September 30, 2015 | 1.932M |
June 30, 2015 | 1.744M |
March 31, 2015 | 0.2697M |
December 31, 2014 | 0.2594M |
September 30, 2014 | 0.3869M |
June 30, 2014 | 0.7647M |
March 31, 2014 | 0.2637M |
December 31, 2013 | 0.3289M |
September 30, 2013 | 0.406M |
June 30, 2013 | 0.4318M |
March 31, 2013 | 0.8815M |
December 31, 2012 | 0.326M |
September 30, 2012 | 0.4246M |
June 30, 2012 | 0.645M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.331M
Minimum
Dec 2019
131.07M
Maximum
Dec 2023
65.14M
Average
66.68M
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Theriva Biologics Inc | 40.11M |
Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 9.522M |
Shareholders Equity (Quarterly) | 92.97M |
Current Ratio | 13.29 |
Net Debt Paydown Yield | 0.19% |